Transrectal Ultrasound Market Growth, Segments, Size, Market Analysis and Opportunities 2031
Global
Transrectal Ultrasound (TRUS) Market Overview
The global transrectal ultrasound (TRUS) market is
expected to grow at a steady CAGR of around 6% during the forecast period. The
market growth is driven by the rising prevalence of prostate cancer, increasing
awareness about early prostate screening, aging population, supportive
reimbursement policies, and the growing number of TRUS procedures. However,
high equipment and procedural costs, along with a shortage of skilled
professionals, remain significant challenges limiting market expansion.
Key Request
a free sample copy or view report summary: https://meditechinsights.com/transrectal-ultrasound-market/request-sample/
Overview
A transrectal ultrasound (TRUS) is a diagnostic imaging technique used to
examine the prostate gland and nearby tissues using sound waves. During the
procedure, a small probe is gently inserted into the rectum to capture
high-frequency sound waves that generate real-time images of the prostate.
These images help in identifying abnormalities such as infections, prostate
enlargement, or tumors. TRUS is also widely used to guide prostate biopsies,
enabling accurate tissue sampling for cancer diagnosis. The procedure is
minimally invasive, typically lasting 15 to 30 minutes, and provides reliable
diagnostic results with minimal discomfort. With continuous advancements in
imaging technology, TRUS remains a preferred method in urology for its
accuracy, patient comfort, and procedural efficiency.
Increasing
Prevalence of Prostate Cancer
The growing incidence of prostate cancer, particularly among elderly males, is
a major factor boosting the demand for transrectal ultrasound procedures. TRUS
is a preferred diagnostic method due to its precision, non-invasiveness, and
ability to provide real-time imaging for early detection and guided biopsies.
According to the U.S. Centers for Disease Control and Prevention (CDC), over
255,000 new prostate cancer cases were reported in 2022, and 33,881 deaths
occurred in 2023. The rising prevalence of prostate cancer, coupled with
expanding prostate screening programs, public awareness initiatives, and an
increase in urological disorders, is significantly contributing to the growth
of the TRUS market.
Technological
Advancements in TRUS Systems
Rapid technological advancements have transformed the transrectal ultrasound
(TRUS) market, improving diagnostic accuracy, image clarity, and overall
procedural efficiency. Modern TRUS systems provide high-resolution imaging and
faster scans, reducing patient discomfort while enhancing visualization of the
prostate, bladder, and rectum. The integration of artificial intelligence (AI)
has further strengthened diagnostic capabilities by enabling automated
detection and classification of abnormalities. AI-powered TRUS systems are now
aiding in the early identification of conditions such as benign prostatic
hyperplasia (BPH), rectal tumors, and pelvic infections. These innovations have
expanded the utility of TRUS beyond urology into areas such as
gastroenterology, supporting better biopsy guidance, treatment planning, and
clinical outcomes.
"By enhancing collaboration, boosting productivity, and streamlining
workflows between radiology and urology, caregivers can confidently provide
their patients with the precise care they deserve," said the Business
Leader of Clinical Informatics at a leading MedTech company.
Market
Drivers
The global
transrectal ultrasound (TRUS) market continues to evolve as technological
advancements, demographic shifts, and growing clinical awareness reshape the
landscape of prostate imaging and diagnosis. One of the primary forces driving
market growth is the rising prevalence of prostate cancer worldwide, which has
significantly increased the need for accurate, early-stage diagnostic tools. As
the aging male population becomes more susceptible to urological disorders,
healthcare providers are increasingly relying on TRUS for routine evaluation
and guided interventions. In addition, heightened awareness campaigns and
improved access to early prostate screening have contributed to growing
procedural volumes across both developed and developing regions.
Favourable
reimbursement structures in many countries are further supporting the adoption
of TRUS systems in hospitals, diagnostic centres, and outpatient clinics.
Another key trend strengthening market demand is the expanding use of
image-guided biopsy procedures. These techniques enhance diagnostic accuracy
and reduce the need for repeat biopsies, making TRUS an essential component in
modern urology practices.
Attractive
Opportunities
Beyond the
current drivers, the market presents several attractive growth opportunities
for manufacturers and healthcare stakeholders. There is a clear shift toward
minimally invasive procedures, prompting demand for advanced TRUS devices that
offer precision, patient comfort, and operational efficiency. The development
of compact and portable ultrasound systems is also opening new avenues,
especially in settings where mobility and cost-efficiency are crucial.
Furthermore, emerging markets across Asia-Pacific, Latin America, and the
Middle East are witnessing increased investments in healthcare infrastructure,
creating significant potential for market expansion.
Competitive
Landscape
The global transrectal ultrasound (TRUS) market is highly competitive, with key
players including GE Healthcare, Koninklijke Philips N.V., KOELIS, FUJIFILM
Corporation, Telemed Medical Systems, Exact Imaging, Hitachi Medical Systems,
Mindray Medical International Limited, Siemens Healthineers AG, and Strata
Imaging. Market participants are focusing on strategies such as product
innovation, strategic collaborations, and geographical expansion to strengthen
their market presence and capitalize on growing demand for advanced prostate
imaging solutions.
Download pdf
Brochure: https://meditechinsights.com/transrectal-ultrasound-market/request-sample/
Global Transrectal
Ultrasound Market Segmentation
According to the
latest report from Medi-Tech Insights, the global transrectal ultrasound market
is analysed in detail across regional and country-level segments from 2023 to
2030. The study provides comprehensive insights by categorizing the market based
on product type, application, technology, and end-user, offering stakeholders a
clear understanding of evolving trends and future opportunities.
Market Size
& Forecast (2023-2030), By Product Type, USD Million
- Cart / Trolley-based
- Portable
Market Size
& Forecast (2023-2030), By Application, USD Million
- Diagnostic
- Prostate Cancer Diagnosis
- Benign Prostatic Hyperplasia
- Others
- Image-guided Biopsy
Market Size
& Forecast (2023-2030), By Technology, USD Million
- 2D Ultrasound
- 3D Ultrasound
- 4D Ultrasound
- Others
Market Size
& Forecast (2023-2030), By End-user, USD Million
- Hospitals
- Diagnostic Imaging Centers
- Specialty Clinics
- Others
About Us:
At Medi-Tech
Insights, we are a global healthcare consulting firm committed to delivering
premium insights and strategic solutions to help our clients navigate the
complex and evolving healthcare landscape. Our team combines deep industry
expertise with data-driven market intelligence to provide actionable insights
that enable smarter decisions and sustainable success.
With a strong
focus on innovation, quality, and impact, Medi-Tech Insights has become a
trusted partner for leading healthcare investors and corporates across the
globe.

Comments
Post a Comment